A Study of [14C]GB491 in Male Healthy Subjects

Summary

This is an open-label, single-center study to evaluate the mass-balance and pharmacokinetics of GB491 in 4-8 healthy male subjects receiving a single oral 150mg dose of GB491 containing approximately 50 uCi of \[14C\]GB491. This study will help understand how the drug appears in the blood, urine, and feces after it is administered. In addition, this study will also evaluate the safety of a single dose of \[14C\]GB491 when given to healthy subjects.

Timeline

Start

2022-09-14

Primary completion

2022-11-14

Completion

2022-11-14

Drugs

Indications